Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413124 | SCV000491729 | uncertain significance | not specified | 2016-11-18 | criteria provided, single submitter | clinical testing | The Y340C variant in the GMPPB gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The Y340C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Y340C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. We interpret Y340C as a variant of uncertain significance. |
Labcorp Genetics |
RCV002058865 | SCV002466453 | likely benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14; Autosomal recessive limb-girdle muscular dystrophy type 2T | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003133248 | SCV003816925 | uncertain significance | not provided | 2019-08-15 | criteria provided, single submitter | clinical testing |